EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Photobiomodulation therapy mitigates cardiovascular aging and improves survival

Sunayana Begum Syed, Ismayil Ahmet iD, Khalid Chakir, Christopher H Morrell, Praveen R Arany iD, Edward G Lakatta

Lasers in Surgery and Medicine · 2023-03 · 55 (3) · 278-293

DOI: 10.1002/lsm.23644 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lasers in Surgery and Medicine, online erschienen am 23.02.2023. Verfasst von Sunayana Begum Syed und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cardiovascular Sciences, NIA, NIH, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Low-Level Light Therapy, COVID-19. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Photobiomodulation (PBM) therapy, a form of low‐dose light therapy, has been noted to be effective in several age‐associated chronic diseases such as hypertension and atherosclerosis. Here, we examined the effects of PBM therapy on age‐associated cardiovascular changes in a mouse model of accelerated cardiac aging.

Methods

Fourteen months old Adenylyl cyclase type VIII (AC8) overexpressing transgenic mice ( n = 8) and their wild‐type (WT) littermates ( n = 8) were treated with daily exposure to Near‐Infrared Light (850 nm) at 25 mW/cm 2 for 2 min each weekday for a total dose of 1 Einstein (4.5 p.J/cm 2 or fluence 3 J/cm 2 ) and compared to untreated controls over an 8‐month period. PBM therapy was administered for 3.5 months (Early Treatment period), paused, due to Covid‐19 restrictions for the following 3 months, and restarted again for 1.5 months. Serial echocardiography and gait analyses were performed at monthly intervals, and serum TGF‐β1 levels were assessed following sacrifice.

Results

During the Early Treatment period PBM treatments: reduced the age‐associated increases in left ventricular (LV) mass in both genotypes ( p = 0.0003), reduced the LV end‐diastolic volume (EDV) in AC8 ( p = 0.04); and reduced the left atrial dimension in both genotypes ( p = 0.02). PBM treatments substantially increased the LV ejection fraction ( p = 0.03), reduced the aortic wall stiffness ( p = 0.001), and improved gait symmetry, an index of neuro‐muscular coordination ( p = 0.005). The effects of PBM treatments, measured following the pause, persisted. Total TGF‐β1 levels were significantly increased in circulation (serum) in AC8 following PBM treatments ( p = 0.01). We observed a striking increase in cumulative survival in PBM‐treated AC8 mice (100%; p = 0.01) compared to untreated AC8 mice (43%).

Conclusion

PBM treatment mitigated age‐associated cardiovascular remodeling and reduced cardiac function, improved neuromuscular coordination, and increased longevity in an experimental animal model. These responses correlate with increased TGF‐β1 in circulation. Future mechanistic and dose optimization studies are necessary to assess these anti‐aging effects of PBM, and validation in future controlled human studies is required for effective clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Low-Level Light TherapyCOVID-19HumansMiceAnimalsInfantTransforming Growth Factor beta1AgingHeart

Stichwörter der Autor:innen

AC8TGF-β1agingheartmicephotobiomodulation

Substanzen

Transforming Growth Factor beta1

Autor:innen und Institutionen

  • Laboratory of Cardiovascular Sciences, NIA, NIH, Baltimore, Maryland, USA.
  • Oral Biology, Surgery, and Biomedical Engineering, University of Buffalo, Buffalo, New York, USA.

ORCID-Profile: Ismayil Ahmet, Praveen R Arany

Förderung

  • Intramural NIH HHS

Zitieren

APA

Syed, S. B., Ahmet, I., Chakir, K., Morrell, C. H., Arany, P. R., & Lakatta, E. G. (2023). Photobiomodulation therapy mitigates cardiovascular aging and improves survival. Lasers in Surgery and Medicine, 55(3), 278-293. https://doi.org/10.1002/lsm.23644

Vancouver

Syed SB, Ahmet I, Chakir K, Morrell CH, Arany PR, Lakatta EG. Photobiomodulation therapy mitigates cardiovascular aging and improves survival. Lasers in Surgery and Medicine. 2023;55(3):278-293. doi:10.1002/lsm.23644

BibTeX
@article{Syed2023,
  author = {Syed, Sunayana Begum and Ahmet, Ismayil and Chakir, Khalid and Morrell, Christopher H and Arany, Praveen R and Lakatta, Edward G},
  title = {Photobiomodulation therapy mitigates cardiovascular aging and improves survival},
  journal = {Lasers in Surgery and Medicine},
  year = {2023},
  volume = {55},
  number = {3},
  pages = {278--293},
  doi = {10.1002/lsm.23644}
}
Kostenlos starten →